Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
November 14, 2024 16:10 ET
|
Fortress Biotech, Inc.
Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or locally...
First American Bank Invests in the Miami Community with New Branch Location
October 21, 2024 13:00 ET
|
First American Bank
We're thrilled to announce the grand opening of our newly remodeled branch in Hialeah, Florida. We are ready to continue serving this beautiful community!
Recovery Unplugged Leads Panel Discussion on Recruitment and Retention at 2024 Mental Health Marketing Conference
October 10, 2024 11:00 ET
|
Recovery Unplugged
Nashville, TN, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Recovery Unplugged is proud to have participated in the 8th annual Mental Health Marketing Conference (MHMC), held from October 1-3 at The Factory at...
TSplus Wraps Up Another Successful Quarter with Major Developments and New Product Enhancements
October 10, 2024 09:34 ET
|
TSplus
TSplus recently held its quarterly meeting in Lyon, where the entire headquarters gathered to celebrate milestones and strategize for the future.
Neon Bloom To Partner With Elevated International For 3rd Party Business Development
October 02, 2024 15:48 ET
|
Neon Bloom Inc.
Neon Bloom To Partner With Elevated International For 3rd Party Business Development
Spark Biomedical Launches New Academic Research Fellowship Program Focused on Medical Device Entrepreneurship
September 26, 2024 12:38 ET
|
Spark Biomedical
Dallas, TX, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, proudly announces the launch of the Spark Biomedical Innovation Fellowship. This...
EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody
September 03, 2024 21:00 ET
|
Shanghai EpimAb Biotherapeutics Co., Ltd.
SHANGHAI and SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, Inc. (“EpimAb” or “EpimAb Biotherapeutics”) a clinical stage biopharmaceutical company specializing in the...
Inaugural Pre-JPM Partnering Week to Wrap Up 2024, Prepare for 2025
August 29, 2024 07:30 ET
|
Big4Bio
New life science partnering conference to debut that prepares and helps industry dealmakers and stakeholders for the JP Morgan Healthcare Conference week
Middle Market Companies Almanac 2025: Profiles of 500 Industry Leading, U.S. Headquartered Middle-Market Corporations
August 15, 2024 09:39 ET
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Almanac of Middle Market Companies 2025: Middle Market Industry Market Research, Statistics, Trends and Leading Companies" book from Plunkett Research...
Evaxion Announces Business Update and Second Quarter 2024 Financial Results
August 14, 2024 07:00 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines,...